At this point, many of us have heard about GLP-1 agonist (glucagon-like peptide-1) medications and their effectiveness in managing type 2 diabetes and aiding weight loss
Audio transcript NINA MOINI: Starting next week, Medicare will begin a new pilot program that will allow some users to access popular weight loss drugs, GLP-1s, at a reduced cost
Wearableschest straps, wrist sensors, or clinical monitorsgive constant feedback and set boundaries
Reliable sourcing reduces operational disruptions while supporting efficient inventory management
Gout Gout patients with diabetes, hypertension, and obesity see increased flares during rapid weight loss (common with GLP-1 or surgery), due to changes in uric acid
The soaring demand for treatments such as Ozempic and Wegovy has catalyzed billions of euros in domestic manufacturing, along with research investments